Cargando…
Noradrenaline plays a critical role in the switch to a manic episode and treatment of a depressive episode
Although antidepressants may increase the risk of switching to mania in bipolar disorder (BD), clinicians have been using antidepressants to treat patients with bipolar depression. Appropriate treatments for bipolar depression remain controversial. In BD, antidepressants comprise a double-edged swor...
Autor principal: | Kurita, Masatake |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036557/ https://www.ncbi.nlm.nih.gov/pubmed/27703355 http://dx.doi.org/10.2147/NDT.S109835 |
Ejemplares similares
-
Lurasidone in treatment of manic episode
por: Sánchez-Rivero, I.
Publicado: (2022) -
The noradrenaline metabolite MHPG is a candidate biomarker between the depressive, remission, and manic states in bipolar disorder I: two long-term naturalistic case reports
por: Kurita, Masatake, et al.
Publicado: (2015) -
The Noradrenaline Metabolite MHPG Is a Candidate Biomarker from the Manic to the Remission State in Bipolar Disorder I: A Clinical Naturalistic Study
por: Kurita, Masatake, et al.
Publicado: (2014) -
Predictors of the Onset of Manic Symptoms and a (Hypo)Manic Episode in Patients with Major Depressive Disorder
por: Boschloo, Lynn, et al.
Publicado: (2014) -
Acute and Long Term Treatment of Manic Episodes in Bipolar Disorder
por: ATAGÜN, Murat İlhan, et al.
Publicado: (2021)